111 Net Change in Long-Term Investments 2018-2025 | YI
111 net change in long-term investments from 2018 to 2025. Net change in long-term investments can be defined as the net cash flows from the sale and purchase of investments with maturities greater than one year.
| 111 Annual Net Change in Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $N/A |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.064B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.644B | 58.07 |
| Doximity (DOCS) | United States | $11.655B | 53.96 |
| Hims & Hers Health (HIMS) | United States | $11.295B | 117.35 |
| Tempus AI (TEM) | United States | $9.675B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.275B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.775B | 58.99 |
| Hinge Health (HNGE) | United States | $3.572B | 0.00 |
| Privia Health (PRVA) | United States | $2.516B | 172.00 |
| Enovis (ENOV) | United States | $1.765B | 9.84 |
| Phreesia (PHR) | United States | $1.591B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| 10x Genomics (TXG) | United States | $1.505B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.461B | 67.89 |
| Evolent Health (EVH) | United States | $1.335B | 113.70 |
| Omnicell (OMCL) | United States | $1.276B | 22.51 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.435B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.321B | 713.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.213B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.120B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |